CNE1000011T7
CNE1000011T7
HYBIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 20.94B EUR | 19.5B EUR | 16.68B EUR | 15.81B EUR |
Enterprise Value | 22.72B EUR | 21.26B EUR | 18.52B EUR | 17.62B EUR |
Valuation Multiples | ||||
Trailing P/E | 158.07x | 96.58x | 98.89x | 142.84x |
Forward P/E | 79.03x | -- | -- | -- |
Price to Sales | 18.95x | 20.07x | 20.29x | 18.99x |
Price to Book | 24.62x | 22.94x | 22.49x | 25.75x |
EV/Revenue | 20.56x | 21.89x | 22.54x | 21.16x |
EV/EBITDA | 68.31x | 63.47x | 61.7x | 72.03x |
Price to FCF (P/FCF) | -- | 4,918.72x | -- | -- |
EV/FCF | -- | 5,363.36x | -- | -- |
FCF Yield | -0.58% | 0.02% | -0.19% | -0.12% |